AIM ImmunoTech

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell AIM ImmunoTech and other ETFs, options, and stocks.

About AIM

AIM ImmunoTech, Inc. is a immuno-pharma company, which focuses on the research and development of therapeutics to treat multiple types of cancers, various viruses and immune-deficiency disorders. Its products include Alferon N Injection and Ampligen. 

CEO
Thomas Kenwood Equels
CEOThomas Kenwood Equels
Employees
23
Employees23
Headquarters
Ocala, Florida
HeadquartersOcala, Florida
Founded
1966
Founded1966
Employees
23
Employees23

AIM Key Statistics

Market cap
4.62M
Market cap4.62M
Price-Earnings ratio
-0.07
Price-Earnings ratio-0.07
Dividend yield
Dividend yield
Average volume
94.99K
Average volume94.99K
High today
$1.70
High today$1.70
Low today
$1.58
Low today$1.58
Open price
$1.67
Open price$1.67
Volume
72.81K
Volume72.81K
52 Week high
$36.00
52 Week high$36.00
52 Week low
$1.55
52 Week low$1.55

Stock Snapshot

With a market cap of 4.62M, AIM ImmunoTech(AIM) trades at $1.66. The stock has a price-to-earnings ratio of -0.07.

During the trading session on 2025-11-08, AIM ImmunoTech(AIM) shares reached a daily high of $1.70 and a low of $1.58. At a current price of $1.66, the stock is +5.4% higher than the low and still -2.4% under the high.

Trading activity shows a volume of 72.81K, compared to an average daily volume of 94.99K.

Over the past 52 weeks, AIM ImmunoTech(AIM) stock has traded between a high of $36.00 and a low of $1.55.

Over the past 52 weeks, AIM ImmunoTech(AIM) stock has traded between a high of $36.00 and a low of $1.55.

AIM News

TipRanks 5d
AIM ImmunoTech announces grant of European patent covering Ampligen

AIM ImmunoTech (AIM) announced that the European Patent Office has officially granted AIM’s European Patent No. 4,096,675, titled “Compositions for Treating LON...

People also own

Based on the portfolios of people who own AIM. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.